52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Humana - Intends To Reaffirm Guidance Of About $18.32 In Diluted Earnings Per Common Share For FY 2019
Humana & Agilon Health Expand Relationship, Announce Value-Based Agreements With Physician Groups
Humana Inc - QTRLY Earnings Per Share $5.03 On An Adjusted Basis
Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, including dental, vision, and other supplemental health and financial protection products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.
500 W Main St
Kurt J. Hilzinger
Independent Chairman of the Board
Bruce D. Broussard
President, Chief Executive Officer, Director
Brian A. Kane
Chief Financial Officer
President - Humana's South Florida Medicare
Elizabeth D. Bierbower
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Humana Inc <HUM.N> reported better-than-expected quarterly earnings and hinted that it could match Wall Street profit targets for 2020 as its main business of selling government-backed Medicare Advantage health insurance plans flourishes.
Humana Inc reported a 14% rise in third-quarter revenue on Wednesday, helped by higher sales in its business that sells government-backed Medicare Advantage health plans.
Health insurer Humana Inc <HUM.N> raised its 2019 profit forecast on Wednesday and beat second-quarter earnings estimates, as it reined in costs and recorded higher revenue from its unit that sells Medicare Advantage health plans.
July 31 - U.S. health insurer Humana Inc reported a 13.9% rise in its second-quarter revenue on Wednesday, helped by higher sales from its business which sells government-backed Medicare Advantage health plans.
Humana Inc said on Monday it would not bid for Centene Corp, quelling speculation that it would acquire the health insurer that has already agreed to buy smaller rival WellCare Health Plans Inc for $15.27 billion.
Humana Inc said https://www.sec.gov/Archives/edgar/data/49071/000119312519163308/d754845d8k.htm on Monday it would not make a proposal to combine with Centene Corp, which in March agreed to buy WellCare Health Plans Inc for $15.27 billion. In a statement, Humana confirmed...
Humana Inc said on Wednesday it would not meet its earnings growth target for 2020 due to a $1.2 billion hit from an industry-wide fee and a proposal to overhaul rebates in health plans, sending its shares down as much as 5 percent.
May 1 - U.S. health insurer Humana Inc reported a 15.3 percent rise in first-quarter profit on Wednesday, on higher sales of its government Medicare health plans for people older than 65 and the disabled.
Humana Inc's full-year profit forecast came in shy of analysts' estimates on Wednesday as its Medicare Prescription drug plans remained under pressure and said it expects 2019 margins in the fast-growing business to fall short of its own targets.
U.S. health insurer Humana Inc reported a 7.4 percent rise in its fourth-quarter revenue on Wednesday, as more customers enrolled in its government-backed Medicare Advantage health plans.
Health insurer Humana Inc <HUM.N> said on Wednesday that enrollment for its 2019 Medicare prescription drug plans dropped as customers opted for lower priced options from rivals.
Health insurer Humana Inc said on Wednesday that it expected membership in its prescription drug plans in 2019 to decline by 750,000 to 800,000, citing intense competition in the prescription drug market.
Drugstore owner Walgreens Boots Alliance Inc <WBA.O> and health insurer Humana Inc <HUM.N> are in preliminary discussions to take equity stakes in each other, the Wall Street Journal reported https://www.wsj.com/articles/walgreens-humana-are-in-preliminary-talks-to-take-stakes-in-each-other...
Drugstore owner Walgreens Boots Alliance Inc and health insurer Humana Inc are in preliminary discussions to take equity stakes in each other, the Wall Street Journal reported https://www.wsj.com/articles/walgreens-humana-are-in-preliminary-talks-to-take-stakes-in-each-other...
U.S. health insurer Humana Inc <HUM.N> on Wednesday reported a third-quarter profit that handily beat Wall Street estimates and raised its full-year earnings forecast as it expects more customers to buy its Medicare Advantage health plans.
U.S. health insurer Humana Inc reported a 29 percent rise in third-quarter profit on Wednesday, helped by its Medicare Advantage business that sells healthcare plans to people over age 65 and the disabled.
Humana Inc <HUM.N> said it was looking to expand its tie-up with Walmart <WMT.N>, easing concerns that the insurer's agreement with drugstore chain Walgreens Boots Alliance <WBA.O> would prevent it from broadening its partnership with the retailer.
Humana Inc's profit fell 70 percent in the second quarter, the health insurer said on Wednesday as it took a charge related to the sale of a unit.
The head of Humana Inc <HUM.N> on Wednesday said the U.S. health insurer is focused on corporate partnerships and small deals to create health clinics, curbing investor hopes of an imminent major transaction as the sector undergoes a seismic consolidation.
* HUMANA-IN SEPT 2018, EXPECTS TO PAY FEDERAL GOVERNMENT $1.05 BILLION FOR PORTION OF ANNUAL HEALTH INSURANCE INDUSTRY FEE ATTRIBUTED TO CALENDAR YEAR 2018
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.